1. Home
  2. MYO vs PMN Comparison

MYO vs PMN Comparison

Compare MYO & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myomo Inc.

MYO

Myomo Inc.

N/A

Current Price

$0.68

Market Cap

36.9M

Sector

Health Care

ML Signal

N/A

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

N/A

Current Price

$21.77

Market Cap

34.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYO
PMN
Founded
2004
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Specialties
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.9M
34.6M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
MYO
PMN
Price
$0.68
$21.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$7.67
$42.67
AVG Volume (30 Days)
367.8K
48.4K
Earning Date
06-09-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
110.28
EPS
N/A
N/A
Revenue
$1,000,000,000.00
N/A
Revenue This Year
$24.07
N/A
Revenue Next Year
$17.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
40814.79
N/A
52 Week Low
$0.64
$0.29
52 Week High
$6.27
$27.40

Technical Indicators

Market Signals
Indicator
MYO
PMN
Relative Strength Index (RSI) 38.18 65.90
Support Level $0.64 $0.43
Resistance Level $1.03 N/A
Average True Range (ATR) 0.06 2.69
MACD 0.00 0.08
Stochastic Oscillator 23.90 59.68

Price Performance

Historical Comparison
MYO
PMN

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: